Crystal Structure of the Catalytic Domain of HIV-1 Integrase: Similarity to Other Polynucleotidyl Transferases
The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index.
Abstract
HIV integrase is the enzyme responsible for inserting the viral DNA into the host chromosome; it is essential for HIV replication. The crystal structure of the catalytically active core domain (residues 50 to 212) of HIV-1 integrase was determined at 2.5 Å resolution. The central feature of the structure is a five-stranded β sheet flanked by helical regions. The overall topology reveals that this domain of integrase belongs to a superfamily of polynucleotidyl transferases that includes ribonuclease H and the Holliday junction resolvase RuvC. The active site region is identified by the position of two of the conserved carboxylate residues essential for catalysis, which are located at similar positions in ribonuclease H. In the crystal, two molecules form a dimer with an extensive solvent-inaccessible interface of 1300 Å 2 per monomer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“All INs harbour three structural domains connected by flexible linkers: the N-terminal domain (NTD), the catalytic core domain (CCD), and the C-terminal domain (CTD).”
From Structure and function of retroviral integrase (2022) · cites this paper as [23]
Citations
Cites
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures
Brünger, A. T. (1992) · Nature · doi:10.1038/355472a0 · Cited by 3,873
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
Complete nucleotide sequence of the AIDS virus, HTLV-III
Ratner, L., Haseltine, W., Patarca, R., Livak, K. J., Starcich, B., Josephs, S. F., Doran, E. R., Rafalski, J. A., Whitehorn, E. A., Baumeister, K., et al. (1985) · Nature · doi:10.1038/313277a0 · Cited by 2,245
Sparse matrix sampling: a screening method for crystallization of proteins
Jancarik, J., & Kim, S. H. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004430 · Cited by 2,049
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914
Nucleotide sequence of the AIDS virus, LAV
Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S., & Alizon, M. (1985) · Cell · doi:10.1016/0092-8674(85)90303-4 · Cited by 1,202
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Research works printed but not linked: 5
- CROUCH, R.J., NEW BIOL 2: 771 (1990).
- Crouch, R. J., Nucleases: 211 (1982).
- Doublie, S., Crystallization of Nucleic Acids and Proteins: 311 (1992).
- Otwinowski,, Z., Data Collection and Processing: 56 (1993).
- Sherratt, D., Mobile DNA: 163 (1989).
Cited by
Items 201–300 of 842
Petit, C., Schwartz, O., & Mammano, F. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7119-7126.2000 · Cited by 78
“The (186)KRK tripeptide is part of a lentivirus-specific exposed loop, called sequence L, which is absent in other retroviruses (12, 15).”
BackgroundWares, M., Mesplède, T., Quashie, P. K., Osman, N., Han, Y., & Wainberg, M. A. (2014) · Retrovirology · doi:10.1186/1742-4690-11-7 · Cited by 77
“the Nterminal domain, the catalytic core domain and the Cterminal domain [4].”
BackgroundEmerging Pharmacology: Inhibitors of Human Immunodeficiency Virus Integration
Hazuda, D. J., Iwamoto, M., & Wenning, L. A. (2008) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145553 · Cited by 78
“This DDE motif coordinates the divalent metal ion cofactor(s) required for the phosphodiester bond cleavage/formation reactions of 3′ processing and strand transfer (23, 24).”
BackgroundPetit, C., Schwartz, O., & Mammano, F. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5079-5088.1999 · Cited by 77
“With the aim of perturbing the structure and the multimeric status of the IN enzyme, we mutated a conserved cysteine into a glycine (C130-G) in the third a-helix of IN, in the proposed dimer interface (19), and analyzed the consequences for viral infectivity and IN multimerization.”
BackgroundInfluentialDidierjean, J., Isel, C., Querré, F., Mouscadet, J.-F., Aubertin, A.-M., Valnot, J.-Y., Piettre, S. R., & Marquet, R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.12.4884-4894.2005 · Cited by 75
“The structures of the HIV-1 RNase H domain and the IN core present strong similitude, and their enzymatic mechanisms are probably also closely related (16, 50).”
BackgroundThe Three-dimensional Structure of a Tn5Transposase-related Protein Determined to 2.9-Å Resolution
Davies, D. R., Braam, L. A. M., Reznikoff, W. S., & Rayment, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11904 · Cited by 78
Self-citationMode of Interaction of G-Quartets with the Integrase of Human Immunodeficiency Virus Type 1
Cherepanov, P., Esté, J. A., Rando, R. F., Ojwang, J. O., Reekmans, G., Steinfeld, R., David, G., Clercq, E. D., & Debyser, Z. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.5.771 · Cited by 77
Kanaya, S., Oobatake, M., & Liu, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32729 · Cited by 75
“The enzyme is structurally homologous to the RNase H domain of human immunodeficiency virus 1 (HIV-1)1 reverse transcriptase (Hostomsky et al., 1993).”
BackgroundInfluentialNovel therapeutic strategies targeting HIV integrase
Quashie, P. K., Sloan, R. D., & Wainberg, M. A. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-34 · Cited by 74
“lished in 1994 [81]; however, despite the insights”
BackgroundJohnson, A. A., Santos, W. L., Pais, G. C. G., Marchand, C., Amin, R., Burke, T. R., Verdine, G. L., & Pommier, Y. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511348200 · Cited by 86
Disruption of the terminal base pairs of retroviral DNA during integration.
Scottoline, B. P., Chow, S., Ellison, V, & Brown, P. O. (1997) · Genes & Development · doi:10.1101/gad.11.3.371 · Cited by 75
Structure-based mutagenesis of the catalytic domain of human immunodeficiency virus type 1 integrase
Engelman, A., Liu, Y., Chen, H., Farzan, M., & Dyda, F. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3507-3514.1997 · Cited by 73
“The structure of the orthorhombic crystal is shown (12); each of the interactions is maintained in the trigonal crystal structure (13).”
BackgroundMethodInfluentialSelf-citationAndrake, M. D., & Skalka, A. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.49.29299 · Cited by 74
DNA transposition: From a black box to a color monitor
Grindley, N. D. F., & Leschziner, A. E. (1995) · Cell · doi:10.1016/0092-8674(95)90132-9 · Cited by 72
“Dyda et al. (1994) suggest that the large distance between the two active sites (about 35 A) makes this dimer unsuitable for the concerted strand transfer reaction at the two ends (which occur just 5 bp apart [ - 17 A in B-DNA] at the target Minireview 1065 Figure 2.”
BackgroundResistance to HIV-1 integrase inhibitors: A structural perspective
Mouscadet, J. F., Delelis, O., Marcelin, A., & Tchertanov, L. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.05.001 · Cited by 84
Active Site Sharing and Subterminal Hairpin Recognition in a New Class of DNA Transposases
Ronning, D. R., Guynet, C., Ton‐Hoang, B., Perez, Z. N., Ghirlando, R., Chandler, M., & Dyda, F. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.026 · Cited by 73
“The structures of the Mu (Rice and Mizuuchi, 1995) and Tn5 (Davies et al., 2000) DDE transposases, along with those of retroviral integrases (Dyda et al., 1994), have defined the architecture of these enzymes.”
BackgroundSelf-citationHIV-1 Integrase as a Target for Antiviral Drugs
Pommier, Y. G., Pilon, A. A., Bajaj, K., Mazumder, A., & Neamati, N. (1997) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029700800601 · Cited by 81
“The Glu-152 located in a disordered loop (amino acids 141-153), and the divalent metals were not detected in the first HIV-1 structure published (Dyda et al., 1994).”
BackgroundThe role of integration and clonal expansion in HIV infection: live long and prosper
Anderson, E. M., & Maldarelli, F. M. (2018) · Retrovirology · doi:10.1186/s12977-018-0448-8 · Cited by 83
The Sleeping Beauty Transposable Element: Evolution, Regulation and Genetic Applications
Ivics, Z., Kaufman, C. D., Zayed, H., Miskey, C., Walisko, O., & Izsvák, Z. (2004) · Current Issues in Molecular Biology · doi:10.21775/cimb.006.043 · Cited by 82
“In addition to the DDE-containing transposases and integrases (Dyda et al., 1994; Davies et al., 2000), crystallographic analyses of the catalytic domains of proteins whose functions are not obviously related to transposition, such as RNAase H (Katayanagi et al., 1990) or RuvC (Ariyoshi et al.,…”
HIV Integrase Inhibitors with Nucleobase Scaffolds: Discovery of a Highly Potent Anti-HIV Agent
Nair, V., Chi, G., Ptak, R. G., & Neamati, N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0508890 · Cited by 73
Do the integrases of LTR-retrotransposons and class II element transposases have a common ancestor?
Capy, P., Langin, T., Higuet, D., Maurer, P., & Bazin, C. (1997) · Genetica · doi:10.1023/a:1018300721953 · Cited by 88
“The functional importance of this signature in the retroviral integrase, and in the transposases of Tc1, mariner, and the bacteriophage Mu (Baker & Luo, 1994; Bushman et al., 1993; Dyda et al., 1994; Skalka, 1993; Vos & Plasterk, 1994) was demonstrated experimentally by amino acid replacement.”
Molecular Dynamics Studies on the HIV-1 Integrase Catalytic Domain
Lins, R. D., Briggs, J. M., Straatsma, T. P., Carlson, H. A., Greenwald, J., Choe, S., & McCammon, J. A. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77453-9 · Cited by 73
“, 1996a) Although divalent ions are known to bind within the active site, none were detected in the crystal structures (Dyda et al., 1994; Bujacz et al., 1996a).”
BackgroundMethodResultInfluentialHIV integrase inhibitors as therapeutic agents in AIDS
Nair, V., & Chi, G. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.539 · Cited by 72
“5 Å was reported over a decade ago [13].”
BackgroundHuang, Q., Li, L., & Yang, S. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.02.002 · Cited by 75
Functional Oligomeric State of Avian Sarcoma Virus Integrase
Bao, K. K., Wang, H., Miller, J. K., Erie, D. A., Skalka, A. M., & Wong, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200550200 · Cited by 69
Muroya, A., Tsuchiya, D., Ishikawa, M., Haruki, M., Morikawa, M., Kanaya, S., & Morikawa, K. (2001) · Protein Science · doi:10.1110/ps.48001 · Cited by 69
Esposito, F., & Tramontano, E. (2014) · Antiviral Chemistry and Chemotherapy · doi:10.3851/imp2690 · Cited by 68
Quashie, P. K., Mésplède, T., Han, Y.-S., Veres, T., Osman, N., Hassounah, S. A., Sloan, R. D., Xu, H., & Wainberg, M. A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01835-13 · Cited by 69
“The ability of integrase to bind viral LTR impacts on the efficiency of the strand transfer reaction (45).”
BackgroundNew Superfamilies of Eukaryotic DNA Transposons and Their Internal Divisions
Bao, W., Jurka, M., Kapitonov, V. V., & Jurka, J. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp013 · Cited by 70
“The catalytic residues are part of a retroviral integrase-like fold, where they are closely positioned (Dyda et al. 1994; Rice and Baker 2001; Hickman et al. 2005).”
BackgroundRational design of 2-pyrrolinones as inhibitors of HIV-1 integrase
Ma, K., Wang, P., Fu, W., Wan, X., Zhou, L., Chu, Y., & Ye, D. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.054 · Cited by 67
Wolfe, A. L., Felock, P. J., Hastings, J. C., Blau, C. U., & Hazuda, D. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.3.1424-1432.1996 · Cited by 67
“Integrase forms multimers in solution (13, 16, 21, 27, 39) and can be cross-linked to DNA as either a monomer or multimer (12, 24, 30).”
BackgroundModeling the Late Steps in HIV-1 Retroviral Integrase-catalyzed DNA Integration
Brin, E., Yi, J., Skalka, A. M., & Leis, J. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006929200 · Cited by 85
RuvC protein resolves Holliday junctions via cleavage of the continuous (noncrossover) strands.
Bennett, R. J., & West, S. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5635 · Cited by 67
Overview of Protein Structural and Functional Folds
Sun, P. D., Foster, C. E., & Boyington, J. C. (2004) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps1701s35 · Cited by 103
“…al. (1990), Yang et al. (1990), Katayanagi et al. (1992) HIV-I reverse transcriptase RNase H 1hrh Davies et al. (1991) RuvC resolvase 1hjr Ariyoshi et al. (1994) HIV-I integrase 1itg Dyda et al. (1994) Mu transposase 1beo Rice and Mizuuchi (1995) TN5 transposase 1f3i Davies et al. (2000) Klenow…”
BackgroundFragment-Based Screening by Protein Crystallography: Successes and Pitfalls
Chilingaryan, Z., Zhou, Y., & Oakley, A. J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012857 · Cited by 80
“From this work, a single-point mutant, F185K, showed a dramatically improved solubility and yielded X-ray-quality crystals [33].”
BackgroundViral enzymes containing magnesium: Metal binding as a successful strategy in drug design
Rogolino, D., Carcelli, M., Sechi, M., & Neamati, N. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.07.006 · Cited by 73
Sgourakis, N. G., Lange, O. F., DiMaio, F., André, I., Fitzkee, N. C., Rossi, P., Montelione, G. T., Bax, A., & Baker, D. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja111318m · Cited by 74
The hepatitis B virus ribonuclease H as a drug target
Tavis, J. E., & Lomonosova, E. E. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.04.002 · Cited by 72
“, 2001), retroviral RNaseH and integrases (Dyda et al., 1994), and many other nucleases and transposases.”
BackgroundIvics, Z., & Izsvák, Z. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mdna3-0042-2014 · Cited by 74
“The emerging picture reinforces the notion of a common structural motif that catalyzes polynucleotidyl transfer reactions in diverse biological contexts (31, 32), and that the different specificities in binding to DNA might have evolved by the apparent acquisition of different DNA-binding domains in the evolution of D…”
BackgroundModeling HIV‐1 integrase complexes based on their hydrodynamic properties
Podtelezhnikov, A. A., Gao, K., Bushman, F. D., & McCammon, J. A. (2002) · Biopolymers · doi:10.1002/bip.10217 · Cited by 72
Billamboz, M., Bailly, F., Lion, C. J., Calmels, C., Andréola, M., Witvrouw, M., Christ, F., Debyser, Z., Luca, L. D., Chimirri, A., et al. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.11.033 · Cited by 64
Cannon, P. M., Byles, E. D., Kingsman, S. M., & Kingsman, A. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.651-657.1996 · Cited by 63
“Note: we altered the reading frame of the published CAEV sequence between nucleotides 4910 (21) and 4952 (11) in order to reveal the full homology to the C region shown.”
BackgroundMethodKey determinants of target DNA recognition by retroviral intasomes
Serrao, E., Ballandras-Colas, A., Cherepanov, P., Maertens, G. N., & Engelman, A. N. (2015) · Retrovirology · doi:10.1186/s12977-015-0167-3 · Cited by 62
“The location of secondary structural elements has been documented crystallographically for HIV-1 [89], ASLV [90], SIV [91], and PFV [2] INs.”
BackgroundSelf-citationBarreca, M. L., Iraci, N., Luca, L. D., & Chimirri, A. (2009) · ChemMedChem · doi:10.1002/cmdc.200900166 · Cited by 70
Basak, A. K., Gouet, P., Grimes, J. M., Roy, P., & Stuart, D. I. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3797-3806.1996 · Cited by 62
“It has been reported for the crystallization of the core of human immunodeficiency virus type 1 integrase that the replacement of a single hydrophobic residue by a hydrophilic one can dramatically increase the solubility of the protein and render the material suitable for crystallization (9).”
BackgroundDirected evolution approach to a structural genomics project: Rv2002 from Mycobacterium tuberculosis
Yang, J. K., Park, M., Waldo, G. S., & Suh, S. W. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0137017100 · Cited by 67
Tn5: A Molecular Window on Transposition
Reznikoff, W. S., Bhasin, A., Davies, D. R., Goryshin, I. Y., Mahnke, L. A., Naumann, T. A., Rayment, I., Steiniger-White, M., & Twining, S. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1891 · Cited by 63
Self-citationMolecular Basis of Substrate Recognition and Degradation by Human Presequence Protease
King, J. V. L., Liang, W. G., Scherpelz, K. P., Schilling, A. B., Meredith, S. C., & Tang, W. (2014) · Structure · doi:10.1016/j.str.2014.05.003 · Cited by 62
“Available M16C structures, atPreP and Fln, have similarly sized chambers (∼13,000Å3 and ∼12,500Å3, respectively), indicating that the upper limit for substrate size determined for atPreP, ∼65 residues, is conserved across species (Figure S2) (Moberg et al., 2003; Stahl et al., 2005).”
BackgroundMethodInfluentialCrystal Structure of the Moloney Murine Leukemia Virus RNase H Domain
Lim, D., Gregorio, G. G., Bingman, C., Martinez-Hackert, E., Hendrickson, W. A., & Goff, S. P. (2006) · Journal of Virology · doi:10.1128/jvi.00750-06 · Cited by 60
“Moreover, the crystal structures of other enzymes that possess nuclease activity show tertiary folding that is very similar to that of the RNases H. These include the catalytic domain of HIV-1 integrase, phage Mu transposase, RuvC (an endonuclease that cleaves Holliday junctions), E. coli exonuclease I, and the exonuc…”
BackgroundFolding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli
Wingfield, P. T., Palmer, I. W., & Liang, S. (1995) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0605s00 · Cited by 60
“The overall topology consists of five β-sheets flanked by helical regions, showing that the integrase domain belongs to a superfamily of polynucleotidyl transferases that includes ribonuclease H (Dyda et al., 1994).”
BackgroundModeling of the Inhibition of Retroviral Integrases by Styrylquinoline Derivatives
Ouali, M., Laboulais, C., Leh, H., Gill, D., Desmaële, D., Mekouar, K., Zouhiri, F., d’Angelo, J., Auclair, C., Mouscadet, J. F., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9911581 · Cited by 61
Christensen, A. M., Massiah, M. A., Turner, B. G., Sundquist, W. I., & Summers, M. F. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0700 · Cited by 59
Sirous, H., Chemi, G., Gemma, S., Butini, S., Debyser, Z., Christ, F., Saghaie, L., Brogi, S., Fassihi, A., Campiani, G., et al. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00574 · Cited by 57
Interaction of the HIV-1 Intasome with Transportin 3 Protein (TNPO3 or TRN-SR2)
Larue, R., Gupta, K., Wuensch, C., Shkriabai, N., Kessl, J. J., Danhart, E., Feng, L., Taltynov, O., Christ, F., Van Duyne, G. D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.384669 · Cited by 59
“HIV-1 IN is composed of three structurally and functionally distinct domains: anNTD that contains a Zn(2) finger motif (58), the CCD that contains the acidic DDE triad that coordinates catalytic Mg(2) ions (59, 60), and a CTD that is highly basic and exhibits an Src homology-3-like-fold (61).”
BackgroundInterfacial peptide inhibitors of HIV-1 integrase activity and dimerization
Zhao, L., O’Reilly, M. K., Shultz, M. D., & Chmielewski, J. A. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00040-4 · Cited by 61
Edwards, T. C., Lomonosova, E. E., Patel, J. A., Li, Q., Villa, J. A., Gupta, A., Morrison, L. A., Bailly, F., Cotelle, P., Giannakopoulou, E., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.04.012 · Cited by 61
“Our initial screens for HBV RNaseH inhibitors focused on compound classes known to inhibit the human immunodeficiency virus (HIV) RNaseH because the two enzymes belong to the nucleotidyl transferase superfamily, which includes the HBV RNaseH, the HIV RNaseH, the HIV integrase, and the human RNaseH1 (huRNaseH1) (Dyda e…”
BackgroundIkeda, T., Nishitsuji, H., Zhou, X., Nara, N., Ohashi, T., Kannagi, M., & Masuda, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11563-11573.2004 · Cited by 59
“These studies of HIV-1 IN identified three functional domains: an N-terminal zinc binding domain (6–8), a central catalytic core domain (7, 11, 18, 57, 63), and a Cterminal nonspecific DNA binding domain (11, 19, 46).”
Kumar, V., & Kannan, K. K. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1491 · Cited by 64
Heteromeric transposase elements: generators of genomic islands across diverse bacteria
Peters, J. E., Fricker, A. D., Kapili, B. J., & Petassi, M. T. (2014) · Molecular Microbiology · doi:10.1111/mmi.12740 · Cited by 58
“TnsB belongs to a large family of proteins utilized by many bacterial transposons and retroviruses sometimes referred to as the DDE recombinase (rve) (pfam00665) (Dyda et al., 1994; Punta et al., 2012).”
BackgroundModel of full-length HIV-1 integrase complexed with viral DNA as template for anti-HIV drug design
Karki, R. G., Tang, Y., Burke, T. R., & Nicklaus, M. C. (2004) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-0365-5 · Cited by 64
Mechanisms of Metal Ion Sorption on Calcite: Composition Mapping by Lateral Force Microscopy
Hay, M. B., Workman, R. K., & Manne, S. (2003) · Langmuir · doi:10.1021/la020647s · Cited by 60
Семенова, Е. А., Johnson, A. A., Marchand, C., Davis, D. A., Yarchoan, R., & Pommier, Y. G. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020321 · Cited by 59
“The topological similarity between the catalytic domain of HIV integrase and the HIV reverse transcriptase RNaseH domain could explain a common mechanism of metal chelation in the enzyme catalytic site(s) (Dyda et al., 1994; Yang and Steitz, 1995).”
BackgroundDesign and Optimization of Tricyclic Phtalimide Analogues as Novel Inhibitors of HIV-1 Integrase
Verschueren, W. G., Dierynck, I., Amssoms, K., Hu, L., Boonants, P. M. J. G., Pille, G. M. E., Daeyaert, F. F. D., Hertogs, K., Surleraux, D. L. N. G., & Wigerinck, P. B. T. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049559q · Cited by 58
Craigie, R. (2007) · Mobile DNA II · doi:10.1128/9781555817954.ch25 · Cited by 58
Self-citationRibonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus
Tramontano, E., Corona, A., & Menéndez-Arias, L. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.104613 · Cited by 53
“Very early in antiretroviral drug discovery, the structure of another HIV-1 enzyme, IN, member of the same polynucleotidyltransferase family, was partially solved (Dyda et al., 1994).”
BackgroundCosti, R., Métifiot, M., Chung, S., Cuzzucoli Crucitti, G., Maddali, K., Pescatori, L., Messore, A., Madia, V. N., Pupo, G., Scipione, L., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5001503 · Cited by 55
Remodeling protein complexes: Insights from the AAA+ unfoldase ClpX and Mu transposase
Burton, B. M., & Baker, T. A. (2005) · Protein Science · doi:10.1110/ps.051417505 · Cited by 69
“This protein superfamily includes many DNA transposases and retroviral/retrotransposon integrases including the Tn5 transposase, HIV integrase (Dyda et al. 1994; Rice and Mizuuchi 1995; Davies et al. 1999).”
BackgroundJääskeläinen, M., Mykkänen, A.-H., Arna, T., Vicient, C. M., Suoniemi, A., Kalendar, R. N., Savilahti, H., & Schulman, A. H. (1999) · The Plant Journal · doi:10.1046/j.1365-313x.1999.00616.x · Cited by 57
3-Hydroxypyrimidine-2,4-diones as an Inhibitor Scaffold of HIV Integrase
Tang, J. Y., Maddali, K., Métifiot, M., Sham, Y. Y., Vince, R., Pommier, Y. G., & Wang, Z. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1014378 · Cited by 60
Bar-Magen, T., Donahue, D. A., McDonough, E. I., Kuhl, B. D., Faltenbacher, V. H., Xu, H., Michaud, V., Sloan, R. D., & Wainberg, M. A. (2010) · AIDS · doi:10.1097/qad.0b013e32833cf265 · Cited by 60
Quinoline-based HIV Integrase Inhibitors
Musioł, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319100008 · Cited by 61
Engelman, A. N., & Cherepanov, P. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.04.005 · Cited by 56
“The outer IN subunits (cyan) fasten to the catalytic protomers via the CCD-CCD dimerization interface [4 ,8].”
BackgroundSelf-citationIdentification of a nucleotide binding site in HIV-1 integrase
Drake, R. R., Neamati, N., Hong, H., Pilon, A. A., Sunthankar, P., Hume, S. D., Milne, G. W. A., & Pommier, Y. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4170 · Cited by 60
Subcellular localization of avian sarcoma virus and human immunodeficiency virus type 1 integrases
Kukolj, G., Jones, K. S., & Skalka, A. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.843-847.1997 · Cited by 57
Dayam, R., & Neamati, N. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.035 · Cited by 61
Jing, N., Clercq, E. D., Rando, R. F., Pallansch, L. A., Lackman-Smith, C., Lee, S., & Hogan, M. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3421 · Cited by 60
Sourgen, F., Maroun, R. G., Frère, V., Bouziane, M., Auclair, C., Troalen, F., & Fermandjian, S. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0765h.x · Cited by 57
“We noted the similarity between the GOR-predicted values and the recently reported X-ray values (Dyda et al., 1994), both demonstrating the existence of a continuous Q helix in the segment 147-175 (the residues 147153 are missing in the crystal; Fig.”
BackgroundResultInfluentialA Three-dimensional Model of the Human Immunodeficiency Virus Type 1 Integration Complex
Wielens, J., Crosby, I. T., & Chalmers, D. K. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-5256-2 · Cited by 64
Analysis of the full-length integrase–DNA complex by a modified approach for DNA docking
Luca, L. D., Pedretti, A., Vistoli, G., Barreca, M. L., Villa, L., Monforte, P., & Chimirri, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.120 · Cited by 56
The Core Domain of HIV-1 Integrase Recognizes Key Features of Its DNA Substrates
Gerton, J. L., & Brown, P. O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25809 · Cited by 60
Design and discovery of HIV-1 integrase inhibitors
Neamati, N., Sunder, S., & Pommier, Y. G. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01105-7 · Cited by 54
Lee, M. C., Deng, J. N., Briggs, J. M., & Duan, Y. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.058446 · Cited by 58
“Because these two steps utilize the same active site and yet involve different substrates, it has been postulated that the active site conformation of IN may be different for each step.”
BackgroundRecognition of core-type DNA sites by λ integrase
Tirumalai, R. S., Kwon, H. J., Cardente, E. H., Ellenberger, T., & Landy, A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1786 · Cited by 53
The Mu story: how a maverick phage moved the field forward
Harshey, R. M. (2012) · Mobile DNA · doi:10.1186/1759-8753-3-21 · Cited by 52
“The catalytic core domains of both MuA and retroviral integrases were the first to be crystallized and showed a striking similarity in their active sites and overall RNase H structural fold [30-33] (Figure 4).”
Kessl, J. J., Li, M., Ignatov, M., Shkriabai, N., Eidahl, J. O., Feng, L., Musier-Forsyth, K., Craigie, R., & Kvaratskhelia, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr581 · Cited by 52
Self-citationBinding Aspects of Baicalein to HIV-1 Integrase
Ahn, H., Lee, S.-Y., Kim, J., Son, W.-S., Shin, C., & Lee, B. (2001) · Molecules and Cells · doi:10.1016/s1016-8478(23)17072-5 · Cited by 52
Structural Determinants of Metal-induced Conformational Changes in HIV-1 Integrase
Asante‐Appiah, E., Seeholzer, S. H., & Skalka, A. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35078 · Cited by 54
Rhodes, D. I., Peat, T. S., Vandegraaff, N., Jeevarajah, D., Le, G. T., Jones, E. D., Smith, J. A., Coates, J. A. V., Winfeld, L. J., Thienthong, N., et al. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1716 · Cited by 52
“Enzymatic activity of integrase requires two magnesium ions to be coordinated by a DDE motif (D64, D116, E152) in the active site of integrase [2], with the position of E152 modulated by the ‘mobile loop’ (residues G140 to G149), suggesting that the loop plays a role in positioning the metals.”
BackgroundBerger, B. W., & Haas, D. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000866 · Cited by 51
McDaniel, Y. Z., Wang, D., Love, R. P., Adolph, M. B., Mohammadzadeh, N., Chelico, L., & Mansky, L. M. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1164 · Cited by 51
“During HIV replication, the viral RNA genome is reverse tran-* scribed from ss(+)RNA to ss( − )DNA and then finally to a dsDNA, which is integrated into the human genome (18– 20).”
HIV‐1 Integrase Inhibitors: Update and Perspectives
Семенова, Е. А., Marchand, C., & Pommier, Y. G. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56007-2 · Cited by 61
“16 Plasterk, 1993) (Table 1); determination of X-ray crystal structures of the core and C-domains (Bujacz et al., 1995; Chen et al., 2000; Dyda et al., 1994) and elucidation”
HIV-1 integrase: the next target for AIDS therapy?
d’Angelo, J., Mouscadet, J. F., Desmaële, D., Zouhiri, F., & Leh, H. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00135-3 · Cited by 52
Gleenberg, I. O., Avidan, O., Goldgur, Y., Herschhorn, A., & Hizi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414679200 · Cited by 55
An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule
Kessl, J. J., Eidahl, J. O., Shkriabai, N., Zhao, Z., McKee, C. J., Hess, S., Burke, T. R., & Kvaratskhelia, M. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058883 · Cited by 50
“Crystallographic studies indicated a dimeric organization of this domain (Dyda et al., 1994).”
BackgroundSchumacher, S., Clubb, R. T., Cai, M., Mizuuchi, K., Clore, G. M., & Gronenborn, A. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7532 · Cited by 50
“The structure of domain II (catalytic core, residues 247–574) has been solved by X-ray crystallography (Rice and Mizuuchi, 1995) and shows high structural similarity to the catalytic cores of human immunodeficiency virus (HIV) and avian sarcoma virus (ASV) integrases (Dyda et al., 1994; Bujacz et al., 1995), as well a…”
BackgroundDicker, I. B., Samanta, H. K., Li, Z., Hong, Y., Tian, Y., Banville, J., Remillard, R. R., Walker, M. A., Langley, D. R., & Krystal, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704935200 · Cited by 50
Gleenberg, I. O., Herschhorn, A., & Hizi, A. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.03.073 · Cited by 158
Botos, I., Melnikov, E. E., Cherry, S., Kozlov, S., Makhovskaya, O. V., Tropea, J. E., Gustchina, A., Rotanova, T. V., & Wlodawer, A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.008 · Cited by 49
“In some cases, the origin of an “inactive” conformation can be traced to covalent modifications with components of the crystallization buffers, such as cacodylate, which was responsible for the inability to bind divalent cations by the catalytic domain of HIV integrase.(36,37) In some other cases, the reasons for rear…”
BackgroundZhao, Z., McKee, C. J., Kessl, J. J., Santos, W. L., Daigle, J. E., Engelman, A., Verdine, G., & Kvaratskhelia, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705241200 · Cited by 49
Self-citationOubridge, C., Ito, N., Teo, C.-H., Fearnley, I. M., & Nagai, K. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0306 · Cited by 49
Metadata
- Authors
- Dyda, F., Hickman, A. B., Jenkins, T. M., Engelman, A., Craigie, R., & Davies, D. R.
- Affiliations
- National Institutes of Health (US)
- Venue
- Science
- Published
- 1994-12-23
- Volume
- 266
- Issue
- 5193
- Pages
- 1981-1986
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2006572311
- Cited by
- 810
- References
- 73
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 11 · 2023: 11 · 2022: 11 · 2021: 8 · 2020: 8 · 2019: 8 · 2018: 14 · 2017: 16 · 2016: 15 · 2015: 27 · 2014: 27 · 2013: 28 · 2012: 19
- FWCI
- 39.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 integrase, catalytic domain, crystal structure, RNase H, RuvC, Holliday junction resolvase, viral DNA integration, HIV replication
- MeSH terms
- Amino Acid Sequence, Binding Sites, Crystallization, DNA Nucleotidyltransferases, Hydrogen Bonding, Models, Molecular, Molecular Sequence Data, Solubility, HIV-1, Virus Integration, Ribonuclease H, Protein Structure, Secondary, Protein Folding, Crystallography, X-Ray, Integrases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.